Rapid Micro Biosystems第四季度每股收益$(0.22)优于预期$(0.23),销售额$822万超预期$780万

财报速递2025-02-28
Rapid Micro Biosystems (NASDAQ:RPID)报告季度每股亏损$(0.22),优于分析师普遍预期的$(0.23),增长了4.35%。这相比去年同期每股亏损$(0.26)增加了15.38%。公司报告季度销售额为822万美元,超出分析师普遍预期的780万美元,增长了5.36%。这比去年同期634万美元的销售额增长了29.68%。

以上内容来自Benzinga Earnings专栏,原文如下:

Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.23) by 4.35 percent. This is a 15.38 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $8.22 million which beat the analyst consensus estimate of $7.80 million by 5.36 percent. This is a 29.68 percent increase over sales of $6.34 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法